Emergency Management of COVID-19 Patient with Lactate 2.2 mmol/L
This patient meets criteria for potential septic shock and requires immediate aggressive fluid resuscitation with at least 30 mL/kg isotonic crystalloid in the first 3 hours, supplemental oxygen therapy, and anticoagulation. 1
Immediate Assessment & Risk Stratification
Your patient's lactate of 2.2 mmol/L is a critical threshold. When lactate ≥2 mmol/L is present with confirmed infection and the patient requires vasopressors to maintain MAP ≥65 mmHg despite adequate fluid resuscitation, septic shock should be considered. 1 Even without frank shock, this lactate level signals increased risk—research shows that COVID-19 patients with lactate ≥2 mmol/L have significantly elevated odds of mortality and ICU admission 2, and this lactate elevation is independently associated with worse outcomes in COVID-19 3, 4.
Check vital signs immediately:
- Blood pressure and MAP
- Oxygen saturation
- Respiratory rate
- Mental status changes
- Signs of poor peripheral perfusion (capillary refill time, skin mottling)
Oxygen Support Strategy
Assess oxygen requirements immediately:
- If SpO2 <93% on room air: Start supplemental oxygen to maintain SpO2 92-96% 5
- If standard oxygen therapy fails: Consider high-flow nasal cannula (HFNC) or noninvasive CPAP (helmet or facemask preferred) 6
- Critical warning: If the patient shows no improvement or worsening within 1-2 hours on HFNC/NIV, or if oxygenation index ≤150 mmHg, proceed immediately to endotracheal intubation and invasive mechanical ventilation 5
Do not delay intubation in deteriorating patients—this is a common pitfall.
Fluid Resuscitation Protocol
Administer at least 30 mL/kg of isotonic crystalloid solution within the first 3 hours. 1 This is approximately 2-2.5 liters for an average adult.
- Use normal saline or lactated Ringer's
- Do NOT use hypotonic crystalloids, starches, or gelatins in the first hour 1
- Albumin may be considered but evidence is low quality 1
Important caveat: While aggressive fluid resuscitation is essential, avoid fluid overload which can worsen gut edema and increase intra-abdominal pressure in patients with generalized peritonitis 7. Monitor closely for signs of volume overload.
Vasopressor Support
If hypotension persists after fluid resuscitation:
- Start norepinephrine as first-line vasopressor 1
- Target MAP ≥65 mmHg 1
- Can be administered through peripheral IV if central access unavailable, but monitor closely for extravasation 1
Corticosteroid Decision
This is oxygen-dependent:
- If requiring supplemental oxygen, noninvasive ventilation, or mechanical ventilation: Give corticosteroids (dexamethasone 6 mg daily is the evidence-based dose) 6
- If NOT requiring supplemental oxygen: Do NOT give corticosteroids 6
The 2021 European Respiratory Society guideline provides strong evidence from the RECOVERY trial showing mortality benefit only in patients requiring oxygen support 6. Earlier 2020 guidelines were more conservative about routine corticosteroid use 1, but the 2021 data supersedes this.
Anticoagulation
Provide prophylactic anticoagulation to all hospitalized COVID-19 patients (strong recommendation despite very low quality evidence) 6. This addresses the significant thrombotic risk in COVID-19.
Additional Supportive Measures
- Antibiotic therapy: Only if bacterial co-infection suspected—avoid empiric broad-spectrum antibiotics without clear indication 1
- DVT prophylaxis: Already covered by anticoagulation recommendation
- Stress ulcer prophylaxis: Standard ICU care 1
- Blood glucose control: Maintain appropriate targets 1
What NOT to Give
Based on strong evidence, do NOT administer:
- Hydroxychloroquine (strong recommendation against) 6
- Azithromycin without bacterial infection 6
- Lopinavir-ritonavir 6
- Colchicine 6
- Interferon-β 6
Monitoring Strategy
Serial lactate measurements are crucial. Research shows that dynamic changes in lactate (ΔLDH) predict outcomes better than single values 8. The lactate-to-albumin ratio also has strong prognostic value 4. Recheck lactate after initial resuscitation to guide ongoing therapy.
Key pitfall to avoid: Don't wait for lactate to reach traditional "severe" thresholds (>4 mmol/L) before acting aggressively. In COVID-19, even modest elevations around 2 mmol/L signal significantly increased risk 2, 3.